Novel detection of pancreatic and duodenal homeobox 1 autoantibodies (PAA) in human sera using luciferase immunoprecipitation systems (LIPS) assay

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 6, 2013, Pages 1202-1210

  Donelan, William ^a   Wang, Hai ^a   Li, Shi Wu ^a   Pittman, David ^a   Li, Yi ^a   Han, Shuhong ^a   Sun, Yu ^a   Carter, Christopher ^a   Atkinson, Mark ^a   Reeves, Westley ^a   Winter, William E ^a   Yang, Li Jun ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Luciferase immunoprecipitation systems (LIPS) assay; Pancreatic and duodenal homeobox 1 (Pdx1); Pdx1 autoantibodies (PAA); Type I diabetes

Indexed keywords

AUTOANTIBODY; DIAGNOSTIC AGENT; GLUTAMATE DECARBOXYLASE; HOMEODOMAIN PROTEIN; HYBRID PROTEIN; ICA512 AUTOANTIBODY; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; PTPRN PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; RENILLA LUCIFERIN 2 MONOOXYGENASE; TRANSACTIVATOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BINDING COMPETITION; BLOOD; CASE CONTROL STUDY; CELL STRAIN HEK293; CHILD; COMPARATIVE STUDY; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; LIQUID LIQUID EXTRACTION; LUCIFERASE IMMUNOPRECIPITATION SYSTEMS (LIPS) ASSAY; MALE; METHODOLOGY; MIDDLE AGED; PANCREATIC AND DUODENAL HOMEOBOX 1 (PDX1); PDX1 AUTOANTIBODIES (PAA); PREDICTIVE VALUE; PRESCHOOL CHILD; RADIOIMMUNOASSAY; YOUNG ADULT;

LUCIFERASE IMMUNOPRECIPITATION SYSTEMS (LIPS) ASSAY; PANCREATIC AND DUODENAL HOMEOBOX 1 (PDX1); PDX1 AUTOANTIBODIES (PAA); TYPE I DIABETES;

ADOLESCENT; ADULT; AUTOANTIBODIES; BINDING, COMPETITIVE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOPRECIPITATION; LIQUID-LIQUID EXTRACTION; LUCIFERASES, RENILLA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOIMMUNOASSAY; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATORS; TRANSFECTION; YOUNG ADULT;

EID: 84883007491     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346: 1685-1691.
2. Atkinson MA and Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221-229.
3. Atkinson MA and Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436.
4. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H and De CP. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
5. Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E and Singh B. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 2001; 50: 2451-2458.
6. Bonifacio E, Lampasona V, Genovese S, Ferrari M and Bosi E. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 1995; 155: 5419-5426.
7. Bottazzo GF, Florin-Christensen A and Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279-1283.
8. Burbelo PD, Ching KH, Mattson TL, Light JS, Bishop LR and Kovacs JA. Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems). Biochem Biophys Res Commun 2007; 352: 889-895.
9. Burbelo PD, Goldman R and Mattson TL. A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins. BMC Biotechnol 2005; 5: 22.
10. Burbelo PD, Groot S, Dalakas MC and Iadarola MJ. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem Biophys Res Commun 2008; 366: 1-7.
11. Burbelo PD, Hirai H, Issa AT, Kingman A, Lernmark A, Ivarsson SA, Notkins AL and Iadarola MJ. Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for auto antibodies to GAD65 and IA-2beta. Diabetes Care 2010; 33: 754-756.
12. Burbelo PD, Hirai H, Leahy H, Lernmark A, Ivarsson SA, Iadarola MJ and Notkins AL. A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2. Diabetes Care 2008; 31: 1824-1826.
13. Chen W, Bergerot I, Elliott JF, Harrison LC, Abiru N, Eisenbarth GS and Delovitch TL. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol 2001; 167: 4926-4935.
14. Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-1617.
15. Hui H and Perfetti R. Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol 2002; 146: 129-141.
16. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK and Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-292.
17. Koizumi M, Doi R, Toyoda E, Masui T, Tulachan SS, Kawaguchi Y, Fujimoto K, Gittes GK and Imamura M. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery 2003; 134: 260-266.
18. Koya V, Lu S, Sun YP, Purich DL, Atkinson MA, Li SW and Yang LJ. Reversal of streptozotocin-induced diabetes in mice by cellular transduction with recombinant pancreatic transcription factor pancreatic duodenal homeobox-1: a novel protein transduction domain-based therapy. Diabetes 2008; 57: 757-769.
19. Lan MS, Wasserfall C, Maclaren NK and Notkins AL. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1996; 93: 6367-6370.
20. Li SW, Koya V, Li Y, Donelan W, Lin P, Reeves WH and Yang LJ. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes. Lab Invest 2010; 90: 31-39.
21. Li SW, Sun Y, Donelan W, Yu H, Scian J, Tang D and Yang LJ. Expression, purification, and characterization of recombinant human pancreatic duodenal homeobox-1 protein in Pichia pastoris. Protein Expr Purif 2010; 72: 157-161.
22. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK, Notkins AL and Lan MS. Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precurReferences sor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A 1996; 93: 2307-2311.
23. Mahon JL, Sosenko JM, Rafkin-Mervis L, Krause-Steinrauf H, Lachin JM, Thompson C, Bingley PJ, Bonifacio E, Palmer JP, Eisenbarth GS, Wolfsdorf J and Skyler JS. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes 2009; 10: 97-104.
24. Noguchi H, Kaneto H, Weir GC and Bonner-Weir S. PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 2003; 52: 1732-1737.
25. Noguchi H, Matsumoto S, Okitsu T, Iwanaga Y, Yonekawa Y, Nagata H, Matsushita M, Wei FY, Matsui H, Minami K, Seino S, Masui Y, Futaki S and Tanaka K. PDX-1 protein is internalized by lipid raft-dependent macropinocytosis. Cell Transplant 2005; 14: 637-645.
26. Noguchi H, Matsushita M, Matsumoto S, Lu YF, Matsui H and Bonner-Weir S. Mechanism of PDX-1 protein transduction. Biochem Biophys Res Commun 2005; 332: 68-74.
27. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK and Paquette TL. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-1339.
28. Park JY, Hong SM, Klimstra DS, Goggins MG, Maitra A and Hruban RH. Pdx1 expression in pancreatic precursor lesions and neoplasms. Appl Immunohistochem Mol Morphol 2011; 19: 444-449.
29. Song SY, Gannon M, Washington MK, Scoggins CR, Meszoely IM, Goldenring JR, Marino CR, Sandgren EP, Coffey RJ Jr, Wright CV and Leach SD. Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology 1999; 117: 1416-1426.
30. Vaziri-Sani F, Oak S, Radtke J, Lernmark K, Lynch K, Agardh CD, Cilio CM, Lethagen AL, Ortqvist E, Landin-Olsson M, Torn C and Hampe CS. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 2010; 43: 598-606.
31. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW and Hutton JC. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007; 104: 17040-17045.
32. Wenzlau JM, Walter M, Gardner TJ, Frisch LM, Yu L, Eisenbarth GS, Ziegler AG, Davidson HW and Hutton JC. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab 2010; 95: 4712-4719.
33. Winter WE and Schatz DA. Autoimmune markers in diabetes. Clin Chem 2011; 57: 168-175.
34. Yokota I, Matsuda J, Naito E, Ito M, Shima K and Kuroda Y. Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM. Diabetes Care 1998; 21: 49-52.
35. Zhang L, Nakayama M and Eisenbarth GS. Insulin as an autoantigen in NOD/human diabetes. Curr Opin Immunol 2008; 20: 111-118.